tetramethylpyrazine has been researched along with Atherosclerosis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, M; Feng, X; Li, S; Liu, P; Wang, J; Wang, Y | 1 |
| Chen, K; Cong, W; Ma, X; Miao, Y; Xin, Q; Yu, M; Yuan, R | 1 |
| Lei, SY; Liu, Y; Ma, LQ; Mao, T; Qiao, Y; Sun, XL; Zhang, JC; Zheng, QX | 1 |
| Chen, F; Fu, R; Guo, Y; Xu, Y; Zhang, Y | 1 |
| Guo, M; Liu, Y; Shi, D | 1 |
| Chen, S; Jiang, F; Liu, C; Qian, J; Zhang, W | 1 |
| Chen, DM; Shi, CG; Sun, MZ; Wang, GF; Wang, HF; Wang, L; Wu, SX; Xu, ZQ | 1 |
| Lu, J; Qu, ZL; Ren, XY; Ruan, QR; Zhu, DH; Zhu, M | 1 |
2 review(s) available for tetramethylpyrazine and Atherosclerosis
| Article | Year |
|---|---|
The role and mechanism of tetramethylpyrazine for atherosclerosis in animal models: A systematic review and meta-analysis.
Topics: Animals; Aortic Diseases; Atherosclerosis; Disease Models, Animal; Humans; Pyrazines | 2022 |
Cardiovascular Actions and Therapeutic Potential of Tetramethylpyrazine (Active Component Isolated from Rhizoma Chuanxiong): Roles and Mechanisms.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Atherosclerosis; Calcium; China; Humans; Pinellia; Pyrazines; Reperfusion Injury; Rhizome | 2016 |
6 other study(ies) available for tetramethylpyrazine and Atherosclerosis
| Article | Year |
|---|---|
Identification of a Novel Angiogenesis Signalling circSCRG1/miR-1268b/NR4A1 Pathway in Atherosclerosis and the Regulatory Effects of TMP-PF In Vitro.
Topics: Apoptosis; Atherosclerosis; Cell Proliferation; Human Umbilical Vein Endothelial Cells; Humans; Lipoproteins, LDL; MicroRNAs; Nuclear Receptor Subfamily 4, Group A, Member 1; Plaque, Atherosclerotic; RNA, Circular | 2023 |
[Intervention effects and mechanism of Chinese herbal medicine of supplementing Qi and activating blood circulation on chronic intermittent hypoxia composite insulin resistance ApoE~(-/-) mice model].
Topics: Animals; Atherosclerosis; Blood Circulation; Drugs, Chinese Herbal; Ginsenosides; Hypoxia; Insulin Resistance; Mice; Mice, Knockout, ApoE; Pyrazines; Qi; Random Allocation | 2019 |
Digital gene expression analysis of the pathogenesis and therapeutic mechanisms of ligustrazine and puerarin in rat atherosclerosis.
Topics: Animals; Atherosclerosis; Gene Expression; Gene Ontology; Isoflavones; Male; Metabolic Networks and Pathways; Oxidative Phosphorylation; Peroxisome Proliferator-Activated Receptors; Pyrazines; Rats; Rats, Wistar | 2014 |
Ligustrazine improves atherosclerosis in rat via attenuation of oxidative stress.
Topics: Animals; Antioxidants; Aorta, Thoracic; Atherosclerosis; Cholesterol; Diet, Atherogenic; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Dyslipidemias; Ligusticum; Lipid Metabolism; Liver; Liver Function Tests; Male; Oxidative Stress; Phytotherapy; Pyrazines; Rats; Rats, Sprague-Dawley; Rhizome; Triglycerides; Vasodilator Agents | 2011 |
Tetramethylpyrazine attenuates atherosclerosis development and protects endothelial cells from ox-LDL.
Topics: Animals; Aorta, Abdominal; Atherosclerosis; Cell Adhesion; Cell Culture Techniques; Cell Movement; Cells, Cultured; Cholesterol; Cholesterol, Dietary; Disease Models, Animal; Endothelial Cells; Immunohistochemistry; Ligusticum; Lipoproteins, LDL; Male; Plaque, Atherosclerotic; Pyrazines; Rabbits; Rats; Rats, Sprague-Dawley; Triglycerides | 2013 |
Tetramethylpyrazine inhibits agiontensin II-induced nuclear factor-kappaB activation and bone morphogenetic protein-2 downregulation in rat vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Atherosclerosis; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Immunohistochemistry; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NF-kappa B; Pyrazines; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta | 2007 |